Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapy

AIM: The objective of the study reported here was to evaluate the therapeutic effects of hapten-enhanced chemoimmunotherapy in the treatment of advanced lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy (UMIPIC) and to analyze the effect of this immune booster. MATER...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Baofa, Lu, Yuanfei, Gao, Feng, Jing, Peng, Wei, Han, Zhang, Peicheng, Liu, Guoliang, Ru, Ning, Cui, Guanghui, Xu, Xinhai, Sun, Chenglin, Guan, Changjiang, Che, Yebing, Wu, Yingli, Ma, Zhenlu, Fu, Qiang, Liu, Jian, Wang, Huan-You
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217516/
https://www.ncbi.nlm.nih.gov/pubmed/28210146
http://dx.doi.org/10.2147/LCTT.S70679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217516/
https://www.ncbi.nlm.nih.gov/pubmed/28210146
http://dx.doi.org/10.2147/LCTT.S70679

Ejemplares similares